Skip directly to searchSkip directly to the site navigationSkip directly to the page's main content

Health Indicator Report of Prostate Cancer Deaths

Prostate cancer is the second most commonly occurring form of cancer for men, after skin cancer, and is the second leading cause of cancer death for men in Utah and the U.S.

Prostate Cancer Deaths per 100,000 Men by Race, Utah, 2005-2014

Notes

ICD-10 codes used to define prostate cancer: C61.   [[br]] Age-adjusted to U.S. 2000 standard population using 3 age groups, 0-44, 45-64, and 65+. [[br]] *Use caution when interpreting rate; the estimates do not meet UDOH standards for reliability.

Data Sources

  • Utah Death Certificate Database, Office of Vital Records and Statistics, Utah Department of Health
  • Population Estimates by Age, Sex, Race, and Hispanic Origin for Counties in Utah, U.S. Bureau of the Census, IBIS Version 2014

Definition

The rate of death from cancer of the prostate (ICD-10: C61) per 100,000 men.

Numerator

The number of deaths due to prostate cancer for a given year (ICD-10: C61).

Denominator

The male population in Utah or the U.S. for a given year.

Healthy People Objective C-7:

Reduce the prostate cancer death rate
U.S. Target: 21.8 deaths per 100,000 males
State Target: currently being revised

Other Objectives

CSTE Chronic Disease Indicators

How Are We Doing?

Utah reached its 2010 goal of less than 28.2 deaths per 100,000 males and now works toward the Healthy People 2020 goal of 21.8 deaths per 100,000 males. In 2014, Utah's age-adjusted prostate cancer mortality rate was 19.7 per 100,000 males. There was no significant difference in prostate cancer mortality among Utah's ethnic or racial groups, with the exception of Utah Asians having significantly lower rates than all races combined.

How Do We Compare With the U.S.?

The U.S. prostate cancer age-adjusted mortality rate has been decreasing. Utah's prostate cancer age-adjusted mortality rate has varied from year-to-year and have closely mirrored national rate. However in recent years Utah rates have been significantly higher than national rates. From 2008-2012, Utah had an age-adjusted rate of 131.7 (131.5-132.0) per 100,000 males compared to the U.S. rate of 156.8 (153.3-160.3) per 100,000 males^1^.[[br]] [[br]] ---- 1. Data based upon CDC's National Program of Cancer Registries Cancer Surveillance System (NPCR-CSS) November 2014 data submission and SEER November 2014 submission. [http://statecancerprofiles.cancer.gov/quick-profiles/index.php?statename=utah].

What Is Being Done?

The Utah Department of Health initiated the Utah Cancer Action Network (UCAN), a statewide partnership whose goal is to reduce the burden of cancer. The mission of the UCAN is to lower cancer incidence and mortality in Utah through collaborative efforts directed toward cancer prevention and control. As a result of this planning process, objectives and strategies have been developed by community partners regarding the early detection of cervical, breast, and colorectal cancers as well as the promotion of physical activity, healthy eating habits, melanoma cancer prevention, and cancer survivorship advocacy.

Evidence-based Practices

Screening recommendations have changed over time. Until recently, many doctors and professional organizations encouraged yearly PSA screening for men beginning at age 50. However, as more has been learned about both the benefits and harms of prostate cancer screening, a number of organizations have begun to caution against routine population screening. Although some organizations continue to recommend PSA screening, there is widespread agreement that any man who is considering getting tested should first be informed in detail about the potential harms and benefits. Currently, Medicare provides coverage for an annual PSA test for all Medicare-eligible men age 50 and older. Many private insurers cover PSA screening as well. Since 2012 the U.S. Preventive Services Task Force (USPSTF) recommends against prostate-specific antigen (PSA)-based screening for prostate cancer. Healthy diet, exercise, and lifestyle play an important role in cancer prevention.

Available Services

Screening recommendations have changed over time. Until recently, many doctors and professional organizations encouraged yearly PSA screening for men beginning at age 50. However, as more has been learned about both the benefits and harms of prostate cancer screening, a number of organizations have begun to caution against routine population screening. Although some organizations continue to recommend PSA screening, there is widespread agreement that any man who is considering getting tested should first be informed in detail about the potential harms and benefits. Currently, Medicare provides coverage for an annual PSA test for all Medicare-eligible men age 50 and older. Many private insurers cover PSA screening as well. Since 2012 The U.S. Preventive Services Task Force (USPSTF) recommends against prostate-specific antigen (PSA)-based screening for prostate cancer.
Page Content Updated On 12/11/2015, Published on 12/23/2015
The information provided above is from the Department of Health's Center for Health Data IBIS-PH web site (http://ibis.health.state.gov). The information published on this website may be reproduced without permission. Please use the following citation: " Retrieved Sat, 27 August 2016 9:18:06 from Department of Health, Center for Health Data, Indicator-Based Information System for Public Health Web site: http://ibis.health.state.gov ".

Content updated: Wed, 23 Dec 2015 12:58:51 MST